A couple of economic and policy factors are currently influencing real estate industry opinion leaders’ predictions for the near future — especially regarding mortage rate changes. For one, President Donald Trump recently announced that he has instructed the federal government to purchase an …
The debate over when the Federal Reserve will finally start cutting rates just picked up a new and unnerving variable: a criminal investigation into the sitting Fed chair. Federal prosecutors have opened a criminal inquiry into Jerome Powell over the roughly $2.5 billion renovation of the Federal …
Fed’s Kashkari optimistic on economy, sees inflation easing
Intel (INTC) stock is up about 9%, at the time of writing, Tuesday afternoon, Jan. 13, thanks to KeyBanc raising its price target to $60, according to Yahoo Finance. The company’s Q4 earnings are near and will be released on January 22. Intel’s competitors, AMD and ARM…
Central bank chiefs, bank CEOs back Fed’s Powell after Trump administration threat
A new year is often meant to symbolize fresh starts, but for one of America’s most recognizable casual dining brands, 2024 delivered the opposite. Instead of renewal, the year was marked by financial troubles, bankruptcy, and a significant loss of its domestic and international footprints. Founded …
The stock market and investment portfolios are continually evolving. With banks recommending the incorporation of cryptocurrencies in their investments and including artificial intelligence and energy growth stocks, another conversation has extended into the new year: Is energy the key to …
When it comes to your money, the chair of the Federal Reserve has more power than you might think. Credit cards? Check.Student loans? Check.Auto loans? Check. Then there’s the impact on mortgage rates, your stock portfolio, and regulation of the nation’s banking industry. Add the U.S…
Bank of America Global Research upped its rating on Regeneron Pharmaceuticals and its price target to $860 because it has a better view on Eylea HD, Dupixent is growing steadily, and there are several catalysts for 2026. Bank of America Global Research raised its rating on Regeneron …
Central bank debates are set to shape first half of 2026, Morgan Stanley says





